Bayer, the German corporation that manufactures birth control pills Yaz, Beyaz and Yasmin, could finance a “significant” acquisition using a combination of debt, equity and its portfolio assets, Bloomberg reports.
Bloomberg cites an interview with Bayer’s Chief Financial Officer Werner Baumann, who said the company would only sell one of its three units “on the merits of its own strategic assessment.”
“You will not find us in a situation where we say we want to buy this, therefore we have to sell that,” Baumann said. “We always look at the intrinsic appeal of a business inside of its industry.”
Bayer is currently facing widespread lawsuits over Yaz, Yasmin, Beyaz, and other birth control pills that contain the compound drospirenone. Plaintiffs claim they weren’t adequately warned of the drug’s harmful side effects, including an increased risk of potentially lethal blood clots, strokes, and pulmonary embolisms.
If you or someone you love developed a blood clot, stroke, or pulmonary embolism while taking Yaz, Yasmin, Beyaz, or Ocella, you may be eligible to recover damages. Contact Lopez McHugh for a free consultation.
See the Bloomberg story here: https://news.businessweek.com/article.asp?documentKey=1376-M03QTM6JIJV901-5N29EOB4PEL5K85UM0LIJ1R5BK
